Both obesity and atrial fibrillation (AF) are increasing in epidemic proportions, and both increase the prevalence of cardiovascular disease events. Obesity has adverse effects on cardiovascular hemodynamics and cardiac structure and function, and increases the prevalence of AF, partly related to electroanatomic remodeling in obese patients. However, numerous studies, including in AF, have demonstrated an obesity paradox, where overweight and obese patients with these disorders have a better prognosis than do leaner patients with the same degree of severity of cardiovascular disease/AF. In this paper, the authors discuss special issues regarding AF in obesity, as well as the evidence that despite the presence of an obesity paradox, there are benefits of weight loss, physical activity/exercise training, and increases in cardiorespiratory fitness on the prognosis of obese patients with AF. (J Am Coll Cardiol 2017;70:2022-35) 
The estimated prevalence in the United States is approximately 5.2 million, and is expected to increase to 12.1 million by the year 2030 (4, 5) . Although numerous factors contribute to this epidemic of AF, the obesity epidemic, which leads to left atrial (LA) remodeling by various mechanisms (4, 6, 7) , is associated with a marked increase in the risk of developing AF. As with other CVDs, however, there is evidence that although obesity increases the risk for the development of AF, overweight and obese patients with AF seem to have a better prognosis, including CVD and all-cause survival, compared to lean AF patients, indicating an apparent obesity paradox (2, 7, 8) .
Although we and others have reviewed the association and impact of obesity on AF (9-11), we believe that this current state-of-the-art review of AF and obesity most comprehensively reviews the adverse effects of obesity on cardiovascular hemodynamics, cardiac structure and function, the electrophysiological effects of obesity, and other mechanisms that may increase the prevalence of AF. We review data on the impact of obesity on prognosis in AF, special management issues in the obese patient with AF, and implications for weight loss and increases in physical activity, exercise training, and improvements in cardiorespiratory fitness (CRF) on prognosis of AF.
OBESITY AND AF: EPIDEMIOLOGICAL CONSIDERATIONS
Early epidemiological studies have uncovered a host of established cardiovascular conditions that are independently associated with the development of AF. More recently, obesity has emerged as an independent risk factor for AF (12) (13) (14) (15) . For example, long-term prospective data from the Framingham Heart Study with almost 14 years of follow-up has identified obesity as an important modifiable risk factor for AF (12) . Importantly, the association between obesity and AF has been shown to be independent of obstructive sleep apnea, a common comorbid condition in obese individuals (13) .
Furthermore, data from the Women's Health Study have elegantly demonstrated the dynamic nature of the risk for AF with weight changes (14) . Specifically, short-term weight gain to BMI >25 kg/m 2 was found to be associated with substantial risk of developing AF, and obese individuals who lost weight to BMI <30 kg/m 2 over 5 years were found to have reduced AF risk similar to those who maintained BMI <30 kg/m 2 over the same period of time (14) .
Obesity represents the second highest populationattributable risk for AF behind hypertension and will likely escalate the global burden of AF in the coming decades given its burgeoning epidemic worldwide (16) . A recent large study reports the association between genetically predicted obesity and AF incidence, making the case that primordial prevention may be needed in the AF epidemic (17) .
The ARIC (Atherosclerosis Risk In Communities) study estimates that almost 1 in 5 cases of AF can be attributable to overweight or obesity (16) , and another report from the ARIC study showed that trajectories of various CVD risk factors many years before the diagnosis of AF impacted the subsequent development of AF (18) . A recent meta-analysis of 51 studies involving more than 600,000 individuals has evaluated the impact of obesity on AF in different clinical scenarios (19) . Specifically, every 5-unit increment in BMI was found to confer an additional 19% to 29% risk of incident AF, a 10% risk of post-operative AF, and a 13% risk of post-ablation AF (19 Obesity is associated with a variety of hemodynamic alterations that predispose to changes in cardiac morphology, which may result in ventricular dysfunction (22) (23) (24) . The effects of obesity on hemodynamics and cardiac structure and function are summarized in Table 1 and Figure 1 . Lavie et al.
Obesity (22) (23) (24) . LVH and associated adverse LV loading conditions many produce LV failure leading to increased left LA pressure and volume, increased pulmonary venous pressure, and an increase in pulmonary capillary pressure (22) (23) (24) (25) (26) . Pulmonary arterial hypertension occurs commonly in severe obesity (22) (23) (24) (25) (26) .
It is due predominantly to left-sided HF, but may be facilitated by hypoxia due to sleep apnea and obesity hypoventilation, both of which occur commonly in severe obesity (22) (23) (24) to be present in nearly all subjects (22) (23) (24) . However, these studies did not exclude comorbidities, such as hypertension and CHD, which could potentially contribute to LA dilation, pressure overload, and hypertrophy. The reported prevalence of LAE in overweight and obese subjects is variable, depending on severity and duration of obesity, the presence or absence of comorbidities, such as hypertension and a variety of metabolic, neurohormonal, and growthpromoting factors, the effects of adiopocytokines and chemokines, and the presence of inflammation (9, (27) (28) (29) . This is discussed in greater detail in the section on pericardial fat and epicardial adipose tissue (EAT). LA remodeling is an important determinant of AF in obese patients (9, (27) (28) (29) (30) (31) (32) (33) .
Some individual studies have reported a significant difference in LA size between obese and nonobese groups (9, (27) (28) (29) (30) (31) (32) (33) . Multiple studies have identified LA size as an independent predictor of AF (9, 20, (27) (28) (29) (30) (31) (32) (33) (34) (35) .
In a 10-year longitudinal study, obesity and hypertension were identified as independent predictors of LAE (35) . Somewhat surprisingly, obesity was found to be a more potent predictor of LAE than hypertension, even after adjusting for age and sex (35) . In a 21-year cohort study of 3,248 patients with paroxysmal AF, BMI and LA volume incrementally predicted risk of developing permanent AF (20) . Lavie et al.
Obesity and Atrial Fibrillation presence of LVH (eccentric or concentric) in association with LV diastolic dysfunction (9, (22) (23) (24) (25) (26) (27) (28) 32) .
The hypercirculatory state serves as both a direct contributor to LAE and as a major cause of LVH, LV diastolic dysfunction, and elevated LA pressure (9, (22) (23) (24) (25) (26) (27) (28) 32) . Hypertension occurs in nearly one-half of obese patients and more than 60% of severely obese patients (22) (23) (24) . Hypertension is a wellestablished cause of LAE, increased LA pressure, and LA hypertrophy. This is due primarily to the development of LVH and LV diastolic dysfunction, but also to comorbidities, such as diabetes mellitus, CHD, and obstructive sleep apnea. All of these comorbidities are commonly associated with obesity and may contribute to LA remodeling and LV diastolic dysfunction by various mechanisms (22) (23) (24) (25) (26) (27) 33) .
Recently, abnormal LA strain has been described during diastole in obese subjects (22) (23) (24) . Increased LA stretch and insufficient LA emptying have also been reported in obese patients (27) . Various neurohormonal, and metabolic factors, growth factors, adipocytokines, and inflammatory markers were described (33) . It has been proposed that many of these factors contribute to LA remodeling and dysfunction in humans, and as such may serve as both triggers and substrates for AF. EAT is thought to be a source of many of these factors. This is discussed in more detail in the following section. The changes in LA morphology may provide a substrate for electrophysiological remodeling of the LA, which may predispose to and perpetuate AF, affecting its severity and the response to catheter ablation.
RELATION OF EAT AND PERICARDIAL FAT TO AF.
In recent years, there has been increasing interest in the role of cardiac fat in the development of AF, particularly EAT and pericardial fat (36) (37) (38) (39) (40) . EAT is located between the visceral pericardium and the epicardial layer of myocardium (36, 37) . Pericardial adipose tissue or pericardial fat is located beyond the parietal pericardium (36, 37) . Both forms of cardiac fat are derived from brown fat, but are embryologically distinct (36, 37) . EAT is highly biologically active. (36, 37) . Pericardial fat is also biologically active and is a depot of visceral adipose tissue (27, 36, 37) . As such, it provides endocrine, paracrine, and autocrine functions that are similar to those of visceral adipose tissue elsewhere in the body (27, 36, 37) . Cardiac adipose is most pronounced over the RV, but can also be found to a lesser extent over the surface of the LV, in the atrioventricular grooves, and along the posterior surface of the LA (22) (23) (24) 36) .
Pericardial fat and EAT have been shown to wrap around the pulmonary veins (PVs) as they enter the LA (36, 37) . EAT contains a dense network of autonomic ganglia (consisting predominantly of parasympathetic nerve fibers) (27, 28, 36, 37) .
Multiple controlled studies employing cardiac imaging techniques (primarily computed tomography)
have demonstrated an association of pericardial fat and AF (36) (37) (38) . Most of these studies did not distinguish between pericardial fat and EAT. It is thought however, that fat deposits directly in contact with LA myocardium (EAT) are more likely to contribute to the development of AF (36) (37) (38) . Nearly all of these studies showed that greater volumes or thicknesses of pericardial fat were associated with a higher prevalence of paroxysmal and persistent AF (36) (37) (38) (39) . In one study, each SD increase in pericardial fat volume was associated with a 28% increase in the prevalence of AF (38) . In another study, a 10% increase in pericardial fat volume increased the odds of AF by 13% (37) . Several studies have reported an association between pericardial fat volume and severity of AF (trends toward persistent AF and more symptoms) (27, (36) (37) (38) (39) . Multiple studies have identified excessive pericardial fat as a predictor of a higher recurrence rate of AF after catheter ablation (27, (36) (37) (38) (39) . In one study, respective pericardial thicknesses of 6.0 and 6.9 mm identified patients who were at higher risk of recurrence of paroxysmal and nonparoxysmal AF after catheter ablation (37) .
Indeed, a recent meta-analysis has suggested that the associations of AF with pericardial fat were stronger than those with abdominal or overall adiposity (40) .
Pericardial fat volumes correlated with complex fragmented LA electrograms in patients with AF (37) .
Excessive interatrial adiposity may also predispose to AF (41).
Obesity, particularly central obesity, is associated with increased pericardial fat volumes (22-24).
In severely obese patients, pericardial fat deposits may be voluminous and more diffuse than in nonobese subjects (22) (23) (24) Lavie et al. Lavie et al.
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